PYC Therapeutics Limited (AU:PYC) has released an update. PYC Therapeutics, a clinical-stage biotech firm focused on RNA therapies, is poised ...

A cutting-edge diagnostic test is helping some doctors find diagnoses for medical mysteries by analyzing DNA and RNA to ...

New guidelines for diabetes treatment, mpox research, and healthcare system improvements discussed in comprehensive health ...

Concurrent DNA and RNA sequencing revealed 15.3% more patients with actionable variants than DNA sequencing alone.

Blocking the METTL3 protein can increase sensitivity to chemotherapy in neuroblastoma, according to research from the ...

CRDMO capabilities are tailored for a full range of mRNA applications, including small-scale quantities for personalized ...

The Antisense & RNAi therapeutics market growth is primarily driven by advancements in drug delivery technologies, like lipid ...

Brad Miller, Moderna's CIO, has driven technology innovation to help drive continued gains for the roughly $7 billion revenue ...

Dolja's research has greatly advanced our understanding of virus-host interactions, viral evolution and the implications of RNA virome diversity on global health and agriculture. His lecture promises ...

Research and Development (R&D) Expenses: R&D expenses were $16.0 million for the three months ended September 30, 2024, as compared to $14.0 million for the same period in 2023. The increase was ...

Researchers at ETH Zurich combined two CRISPR-Cas methods to decipher how mutations in a cell’s genome affect its function.